Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08BKE
|
||||
| Former ID |
DNC008958
|
||||
| Drug Name |
Isosorbide-2-benzylcarbamate-5-triflate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H16F3NO9S
|
||||
| Canonical SMILES |
C1C(C2C(O1)C(CO2)OC(=O)OS(=O)(=O)C(F)(F)F)OC(=O)NCC3=CC<br />=CC=C3
|
||||
| InChI |
1S/C16H16F3NO9S/c17-16(18,19)30(23,24)29-15(22)28-11-8-26-12-10(7-25-13(11)12)27-14(21)20-6-9-4-2-1-3-5-9/h1-5,10-13H,6-8H2,(H,20,21)/t10-,11+,12+,13+/m0/s1
|
||||
| InChIKey |
WOSIHMSPFKVEAI-UMSGYPCISA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | J Med Chem. 2008 Oct 23;51(20):6400-9. Epub 2008 Sep 26.Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.